Showing 20 of 112 recruiting trials for “Adult hepatocellular carcinoma”
Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC
🏥 Second Affiliated Hospital of Guangzhou Medical University📍 1 site📅 Started Nov 2022View details ↗
A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents
Atezolizumab+Bevacizumab+SBRT in Unresectable HCC
Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC
👨⚕️ Wenxiong Xu, Doctor, Third Affiliated Hospital, Sun Yat-Sen University📍 1 site📅 Started Aug 2022View details ↗
Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients
👨⚕️ Maen Abdelrahim, MD, The Methodist Hospital Research Institute📍 1 site📅 Started Jun 2022View details ↗
RecruitingNCT05534906 ↗
The Detection of Small Early Liver Cancer With Natural History Follow up
Liver Cancer Disparities in American Indian and Alaska Native Persons
A National Phase II Study of Proton Therapy in Hepatocellular Carcinoma
👨⚕️ Britta Weber, MD PhD, Danish Center of Particle Therapy📍 3 sites📅 Started Apr 2022View details ↗
Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma
T-Cell Therapy (ECT204) in Adults With Advanced HCC
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)
RecruitingNCT04792801 ↗
PET TDM FDG-Choline as a Decision-making Tool for Routine Care on the Liver Transplant List for HCC
Artificial Intelligence vs. LIRADS in Diagnosing HCC on CT
Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA)
Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors
👨⚕️ Zhenfeng Zhang, MD, PhD, Second Affiliated Hospital of Guangzhou Medical University📍 1 site📅 Started Jan 2021View details ↗
Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma
Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
👨⚕️ Zhenfeng Zhang, MD, PhD, Second Affiliated Hospital of Guangzhou Medical University📍 1 site📅 Started Nov 2020View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →